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Introduction
Metabolic syndrome (MS) is characterized by a group of car-
diovascular risk factors, including obesity, hypertension, dys-
lipidemia, and disturbed glucose metabolism that are associat-
ed with an excess risk of cardiovascular disease.1-3) Previous 
studies have demonstrated a significant correlation between 
obesity and insulin resistance and adverse left ventricular (LV) 
structure and function and an increased risk of congestive 
heart failure.4-8) These findings suggest that increased cardio-
vascular risk may be mediated by LV dysfunction. Several 
studies have shown that subclinical diastolic dysfunction is ev-
ident in most patients with obesity and MS9)10) with either in-
creased or no interval change in LV systolic function at 
rest.9)11)12) A study by Sasso et al.9) demonstrated a reduced in-
crease in ejection fraction in obese subjects during dynamic 
exercise using radionuclide ventriculography; however, ejec-
tion fraction is a load-dependent measurement of systolic 
function that may not accurately reflect the subtle changes of 
early myocardial dysfunction. Moreover, no studies have been 
performed on the effect of MS on myocardial contractile re-
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Background: Metabolic syndrome (MS) is associated with increased left ventricular (LV) mass and diastolic dysfunction. This 
study uses relatively load-independent Doppler tissue echocardiography to examine whether MS is associated with decreased 
longitudinal contractile reserve during dynamic exercise. 
Methods: A total of 112 patients with relatively well-controlled, treated hypertension who complained of exertional dyspnea 
were enrolled (average age: 56.7 ± 10.5 years). Fifty-six were non-diabetic patients with MS (Group 1), and 56 were age-sex 
matched hypertensive patients without MS (Group 2). Exercise stress echo was performed using a symptom-limited, multistage, 
supine bicycle exercise test. Multiple Doppler parameters were obtained at baseline, at each stage of exercise, and during recovery.
Results: There was no significant difference between the two groups in terms of age, gender, and hemodynamic variables. E/
E’, an index of LV filling pressure, was significantly higher in the MS group at rest and during exercise. The longitudinal 
contractile reserve, the change in S’ (longitudinal tissue velocity) from baseline to peak exercise, was significantly lower in the MS 
group (2.00 ± 1.65 vs. 2.90 ± 1.66, p = 0.015). Multiple regression analysis showed independent association of MS with 
longitudinal contractile reserve when controlled for confounding factors, such as LV mass index, gender, blood pressure, and age 
(β = -0.235, p = 0.035). 
Conclusion: Longitudinal contractile reserve was reduced in MS patients compared to others, although both groups 
demonstrated similar longitudinal contractile function at rest. We present the first demonstration that metabolic syndrome is 
independently associated with LV systolic dysfunction during exercise in hypertensive patients.   
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serve during dynamic exercise. 
Therefore, we sought to determine whether MS is associated 
with decreased longitudinal contractile reserve with exaggera-
tion of diastolic dysfunction during dynamic supine bicycle 
exercise, using relatively load-independent Doppler tissue 
echocardiography. 
Methods
Subjects
A total of 212 patients (aged 36-76 years, average age: 56.7 
± 10.5) with relatively well-controlled, treated hypertension 
and who complained of exertional dyspnea were initially en-
rolled in this study after providing informed consent. Fifty-six 
patients satisfied the Asian modified criteria of MS.13)14) From 
the remaining 156 patients, 56 non-diabetic patients, matched 
for age and sex, were selected as controls. Patients with diabe-
tes were excluded due to the possible confounding effect of di-
abetes on myocardial function. Patients with any of the fol-
lowing were also excluded: valvular heart disease, peripheral 
vascular disease, significant systemic disease, history of inflam-
matory disease, symptomatic cerebrovascular disease (includ-
ing previous transient ischemic attack within the previous six 
months), history of significant coronary artery disease, a clini-
cally significant atrioventricular conduction disturbance, his-
tory of atrial fibrillation or other serious arrhythmia, history of 
congestive heart failure, liver cirrhosis, severe hypertension (> 
180/110 mm Hg), serum creatinine > 1.4 mg/dL, pregnancy, 
or lack of appropriate contraception use in women of child-
bearing potential. Use of the following drugs was not permit-
ted during the study: antihypertensive medications other than 
the study agents, lithium, major psychotropic agents, oral ste-
roids, daily nonsteroidal anti-inflammatory drugs, high-dose 
acetylsalicylic acid, or drugs with possible interactions with 
the study drugs (digoxin, cimetidine, rifampin, erythromycin, 
itraconazole, grapefruit juice). All patients underwent a com-
plete physical examination and laboratory assessment at the 
time of enrollment. 
Classification of metabolic status
National Cholesterol Education Program (NCEP) 
criteria of metabolic syndrome (MetS) and modified 
NCEP criteria for asians
The National Cholesterol Education Program adult treat-
ment panel III (ATP III) guidelines classify individuals as hav-
ing MS if they possess three or more of the following criteria:
High blood pressure (BP): systolic BP > 130 mm Hg and/
or diastolic BP > 85 mm Hg or use of BP-lowering drugs.
Hyperglycemia: fasting plasma glucose ≥ 6.1 mmol/L (110 
mg/dL) or use of glucose-lowering drugs.
Hypertriglyceridemia: fasting plasma triglycerides ≥ 1.69 
mmol/L (150 mg/dL).
Low high-density lipoprotein-cholesterol (HDL-C): fasting 
HDL-C < 1.04 or 1.29 mmol/L (40 or 50 mg/dL) for males 
and females, respectively.
Central obesity: The World Health Organization Western 
Pacific Region has recognized the disproportionate contribu-
tion of obesity to the development of cardiovascular risk fac-
tors in Asians and has provisionally lowered the classification 
of central obesity to waist circumference > 80 cm in females 
or > 90 cm in males and/or body mass index ≥ 25 kg/m2 for 
both sexes.
Two-dimensional (2D) and Doppler 
echocardiography 
Echocardiography was performed using an ultrasound sys-
tem (Vivid-7, GE Vingmed, Horten, Norway) with a 2.5-
MHz transducer. Standard 2D measurements (end-diastolic 
and end-systolic dimensions, ventricular septum and posterior 
wall thickness, left atrial volume index, LV mass index, LV 
outflow tract) were made with the patient in the left lateral 
position. The LV ejection fraction was calculated by the modi-
fied method of Quinones et al.15) Tissue Doppler imaging was 
performed in an apical 4-chamber view with the sample vol-
ume placed at the septal border of the mitral annulus. To eval-
uate LV filling pressures, the ratio mitral inflow peak velocity 
(E)/early diastolic tissue velocity of the mitral annulus (E’) was 
calculated. 
Exercise stress echocardiography
Exercise stress echo was performed using a symptom-limit-
ed, multistage, supine bicycle exercise test with a variable load 
bicycle ergometer (Medical Positioning Inc., Kansas City, 
MO, USA), as described previously.16) Briefly, after obtaining 
images at rest, patients pedaled at constant speed, beginning 
at a workload of 25 W and adding an incremental workload 
of 25 W every 3 minutes. From the apical window, a 1- to 
2-mm pulsed Doppler sample volume was placed at the mi-
tral valve tip, and mitral flow velocities from 5 to 10 cardiac 
cycles were recorded. The mitral inflow velocities were traced, 
and the following variables were obtained: early mitral peak 
velocity (E), late velocity (A), and the deceleration time of the 
E wave velocity. Mitral annulus velocity was measured by 
Doppler tissue imaging using the pulsed wave Doppler mode. 
Annular systolic tissue velocities (S’) and E’ were measured 
from the apical 4-chamber view with a 2- to 5-mm sample 
volume placed at the septal corner of the mitral annulus. Mea-
surements were recorded with simultaneous electrocardiogra-
phy at sweep speeds of 50 to 100 mm/s. Each measurement 
was made at baseline at each stage of exercise and during re-
covery. Due to the high incidence of fusion of E’ and A’ during 
exercise at workloads greater than 50 W, parameters of dia-
stolic function were assessed at baseline, 25 W, and 50 W. 
Due to the fact that measurement of S’ was readily obtainable 
during peak exercise, exercise contractile reserve was assessed Journal of Cardiovascular Ultrasound 19 | December  2011
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at peak exercise. Two-dimensional echocardiographic images 
were recorded at rest and at each stage of exercise and digitally 
stored for further analysis. Measurements were performed off-
line by a single investigator who was unaware of the status of 
the study patients. Patients who demonstrated evidence of 
overt myocardial ischemia during exercise, such as significant 
ST segment change or development of regional wall motion 
abnormality, were excluded from analysis. 
Statistical analysis 
Values were expressed as mean ± SD. Comparison of the di-
chotomous variables was performed using the Chi-square 
analysis. Comparison of continuous variables between the two 
study groups was performed using the Student’s t-test. Inde-
pendent clinical predictors of exercise associated elevation of S’ 
(myocardial contractile reserve) were determined using multi-
ple linear regression analysis. Statistical analysis was per-
formed with the SPSS 11.0 statistical program (SPSS Inc., 
Chicago, IL, USA).
Results
Among the 112 patients who were enrolled in this study, 
56 were non-diabetic patients with MS (Group 1), while 56 
were age-sex-matched hypertensive patients without metabol-
ic syndrome (Group 2).      
There were no significant differences between the two groups 
in terms of age, gender, baseline BP, or total cholesterol level 
(Table 1). However, patients in Group 1 demonstrated signifi-
cantly higher BMI, serum triglyceride, and fasting blood sug-
ar level and significantly lower HDL cholesterol level com-
pared to Group 2 (Table 1). Although there was no significant 
difference in the LV dimension and baseline LV ejection fraction 
between Groups 1 and 2, Group 1 demonstrated significantly 
higher relative wall thickness and LV mass index (Table 1). 
There were no significant differences between the two groups 
with respect to the types of anti-hypertensive medications ad-
ministered. 
Hemodynamic variables, such as systolic BP, diastolic BP, 
heart rate, and ejection fraction (EF) during peak exercise were 
not significantly different between the two groups. Fifty pa-
tients in each group performed exercise of more than 50 W 
with no significant difference in exercise duration and meta-
bolic equivalents achieved during exercise (Table 2). 
Comparison of the Doppler echocardiographic parameters 
at baseline and during exercise at 25 W and 50 W showed no 
significant difference in terms of the E/A ratio, deceleration 
time, or E’. However, E/E’, an index of LV filling pressure, was 
significantly higher in patients with MS at rest and at 25 W 
Table 1. Baseline clinical and echocardiographic characteristics
Group 1 (n = 56) Group 2 (n = 56) p-value*
Age   56.5 ± 10.9   56.7 ± 10.2 0.894
Gender (M : F) 21 : 35 21 : 35 1.000
BMI (kg/m
2) 26.2 ± 2.7 23.9 ± 2.5 < 0.001
FBS (mg/dL) 101.5 ± 16.2 92.8 ± 8.3 0.001
Total cholesterol (mg/dL) 200.1 ± 32.6 193.7 ± 26.3 0.252
Triglyceride (mg/dL)   213.7 ± 128.7 121.3 ± 54.7 < 0.001
HDL (mg/dL) 43.5 ± 9.2   55.8 ± 10.3 < 0.001
LVEDD (mm) 48.8 ± 4.5 48.0 ± 3.9 0.335
LVESD (mm) 31.7 ± 4.5 31.2 ± 3.4 0.569
IVS thickness (mm) 10.6 ± 2.1   9.4 ± 1.6 0.001
PW thickness (mm) 10.4 ± 1.7   9.3 ± 1.5 0.001
RWT   0.43 ± 0.09   0.39 ± 0.07 0.008
LVEF (%) 67.6 ± 6.7 66.3 ± 6.1 0.282
LA volume index (mL/m
2) 22.5 ± 7.3 20.4 ± 6.4 0.120
LV mass (gram) 189.5 ± 49.9 157.6 ± 39.9 < 0.001
LV mass index (gram/m
2) 109.3 ± 28.5   97.8 ± 23.1 0.049
Diuretics (%)   5/56   8/56 0.376
CCB (%) 20/56 13/56 0.147
Beta blockers (%) 20/56 11/56 0.057
ACEI (%)   7/56   9/56 0.589
ARB (%) 14/56 11/56 0.496
*p-value < 0.05 is considered significant. Group 1: metabolic syndrome, Group 2: non metabolic syndrome. BMI: body mass index, FBS: fasting blood sugar, 
HDL: high density lipoprotein, LVEDD: left ventricular end diastolic dimension, LVESD: left ventricular end systolic dimension, IVS: interventricular septum, 
PW: posterior wall, RWT: relative wall thickness, LVEF: left ventricular ejection fraction, LA: left atrial, CCB: calcium channel blocker, ACEI: ACE inhibitors, 
ARB: angiotensin receptor blockersMetabolic Syndrome and Myocardial Contraction | Tae Hoon Ha, et al.
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of exercise, with borderline statistical significance at 50 W. In 
addition, the proportion of patients with E/E’ greater than 15 
was higher among patients with MS at rest and at 25 W and 
showed a tendency to be higher at 50 W. Although the abso-
lute value of S’ was not significantly different between the two 
groups at baseline, 25 W and 50 W, there was a tendency for 
a lower S’ value in the MS group. The change of S’ from base-
line, the longitudinal contractile reserve, also tended to be lower 
in the MS group at 25 W and 50 W of exercise. At peak exer-
cise, the longitudinal contractile reserve was significantly low-
er in the MS group (2.00 ± 1.65 vs. 2.90 ± 1.66, p = 0.015)
(Table 3) (Fig. 1).
Multiple regression analysis was performed to determine 
the independent association of MS with longitudinal contrac-
tile reserve when controlled for confounding factors, such as 
LV mass index, gender, BP, and age. The results show that LV 
mass index (β = -0.389, p = 0.001), male gender (β = 0.290, p 
= 0.016), age (β = -0.252, p = 0.033), and MS (β = -0.235, p 
= 0.035) were independently associated with the degree of 
longitudinal contractile reserve (Table 4).
Discussion
The novel finding of our study was that metabolic syn-
drome (MS) influences both systolic and diastolic function 
during exercise. Longitudinal contractile reserve was reduced 
in hypertensive patients with MS compared to patients with-
out MS, although both groups demonstrated similar longitu-
dinal contractile function at baseline. Moreover, E/E’, an index 
of diastolic function and LV filling pressure, was significantly 
increased at each stage of exercise in patients with MS. This 
demonstrates that increased filling pressure and diastolic dys-
function was maintained during dynamic exercise as well as in 
the resting state, as shown in previous studies.5)10)17)
 
MS and cardiac remodeling
Several components of the insulin resistance syndrome are 
associated with increased LV relative wall thickness, LV con-
centric remodeling,18) and LV hypertrophy.19)20) Components 
of MS were associated with increased LV mass in a large cohort 
of blacks in the Atherosclerosis Risk in Communities Study21); 
however, up to 23% of the population in that study had frank 
diabetes, a well-known determinant of LV hypertrophy.22) 
Therefore, the possibility of diabetes playing a significant role 
in the association between metabolic factors and LV mass 
could not be excluded. The present study directly explored 
the association between MS and cardiac structure and function 
in non-diabetic hypertensive patients, thus excluding the in-
fluence of diabetes.
In this study, we demonstrated a close linkage between meta-
bolic components and LV geometric changes. LV concentric 
remodeling was evidenced by increased LVM index, increased 
LV wall thickness, increased relative wall thickness (RWT), 
and normal LV chamber size. This finding is very important, 
since LV concentric remodeling is associated with increased 
cardiovascular morbidity and mortality in the absence of defi-
nite LV dysfunction.23) 
Table 2. Comparison of hemodynamic variables at rest and during exercise
Group 1 (n = 56) Group 2 (n = 56) p-value*
Systolic BP (mm Hg)
    Rest 134.0 ± 16.2 134.1 ± 16.9 0.973
    25 W 155.9 ± 20.4 161.8 ± 24.6 0.175
    50 W 166.9 ± 22.1 170.1 ± 22.8 0.482
    Peak exercise 178.2 ± 24.8 183.2 ± 23.8 0.306
Diastolic BP (mm Hg)
    Rest   80.9 ± 11.6   82.9 ± 10.2 0.336
    25 W   89.3 ± 10.9   91.0 ± 11.4 0.419
    50 W   92.5 ± 14.4   95.1 ± 12.8 0.349
    Peak exercise   94.1 ± 15.6   95.1 ± 13.3 0.747
HR
    Rest 63.2 ± 9.9 65.2 ± 9.4 0.303
    25 W   94.8 ± 15.4   98.7 ± 15.1 0.184
    50 W 105.1 ± 17.7 109.9 ± 15.6 0.150
    Peak exercise 115.5 ± 20.8 121.4 ± 19.7 0.147
EF (%)
    Rest 67.6 ± 6.7 66.3 ± 6.1 0.282
    ΔEF   8.7 ± 5.3   7.7 ± 5.8 0.584
Exercise duration (sec)   538.4 ± 213.7   541.1 ± 215.7 0.947
METS achieved   5.52 ± 1.35   5.98 ± 1.40 0.229
*p-value < 0.05 is considered significant. METS: metabolic equivalents, BP: blood pressure, HR: heart rate, EF: ejection fractionJournal of Cardiovascular Ultrasound 19 | December  2011
180
Table 3. Comparison of Doppler echocardiographic variables at rest and during exercise
Group 1 (n = 56) Group 2 (n = 56) p-value*
E/A
    Rest 0.96 ± 0.39 0.92 ± 0.29 0.476
    25 W 1.09 ± 0.37 (n = 46) 1.04 ± 0.21 (n = 48) 0.475
    50 W 1.12 ± 0.34 (n = 38) 1.13 ± 0.24 (n = 39) 0.849
DT (msec)
    Rest 214.7 ± 54.7 215.4 ± 48.5 0.945
    25 W 166.3 ± 51.8 (n = 46) 155.4 ± 38.2 (n = 45) 0.259
    50 W 139.1 ± 23.9 (n = 31) 142.2 ± 32.4 (n = 38) 0.658
E’ (cm/sec)
    Rest 5.50 ± 1.81 5.93 ± 1.90 0.239
    25 W 7.94 ± 2.52 (n = 47) 8.74 ± 2.26 (n = 48) 0.109
    50 W 8.43 ± 2.37 (n = 40) 9.20 ± 1.85 (n = 40) 0.111
E/E’
    Rest 12.2 ± 4.5 10.5 ± 2.9 0.019
    25 W  13.1 ± 5.7 (n = 45) 10.9 ± 3.1 (n = 47) 0.023
    50 W 13.3 ± 4.9 (n = 37) 11.4 ± 2.7 (n = 36) 0.054
E/E’ over 15
    Rest (%) 13/56 5/56 0.032
    25 W (%) 13/45 4/47 0.012
    50 W (%) 10/37 4/36 0.084
S’
    Rest 6.21 ± 1.13 6.27 ± 1.21 0.809
    25 W 7.23 ± 1.52 (n = 46) 7.66 ± 1.82 (n = 52) 0.215
    50 W 8.08 ± 1.81 (n = 41) 8.42 ± 1.93 (n = 46) 0.409
    Peak 8.21 ± 1.90 (n = 40) 9.03 ± 2.15 (n = 43) 0.071
Change of S’ (cm/sec)
    Baseline to 25 W 0.96 ± 1.31 1.42 ± 1.50 0.116
    Baseline to 50 W 1.77 ± 1.58 2.20 ± 1.29 0.166
    Baseline to Peak  2.00 ± 1.65 2.90 ± 1.66 0.015
*p-value < 0.05 is considered significant. DT: deceleration time
Fig. 1. Annular systolic tissue velocity at rest and during exercise (longitudinal contractile reserve).
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MS syndrome and LV dysfunction
Obesity and insulin resistance syndrome are known to in-
crease the risk of congestive heart failure. Even in patients 
without overt cardiovascular disease, obesity and MS has been 
associated with subclinical myocardial dysfunction.5-8) Al-
though subclinical diastolic dysfunction is evident in most pa-
tients with obesity and MS,9)10) the effect of metabolic syn-
drome on systolic function is not clear,9)11)12) with some studies 
reporting an increase in LV systolic function associated with 
subclinical diastolic dysfunction.9) Although conventional 
measures of LV systolic function, such as left ventricular ejec-
tion fraction, may be preserved in patients with subclinical 
myocardial dysfunction and diastolic dysfunction, this may re-
flect radial compensation for a decrease in longitudinal systolic 
dysfunction.24-26) Due to the fact that longitudinal fibers that 
anatomically connect the mitral annulus are mainly subendo-
cardial fibers, they are more sensitive to early changes of isch-
emia and fibrosis.26)27) Therefore, measurement of systolic and 
diastolic mitral annulus tissue velocity may be a sensitive 
method for the detection of subclinical dysfunction of longitu-
dinal myocardial contraction.28)29) 
Obesity and insulin resistance are characterized by altera-
tions in myocardial metabolism, further defined by derange-
ment in fatty acid metabolism and metabolic deficiency.5) 
The increased myocardial oxygen consumption that is asso-
ciated with insulin resistance syndrome may be exaggerated 
during dynamic exercise. In addition, obesity and MS are as-
sociated with increased LV mass that may contribute to myo-
cardial dysfunction. Although an increase in LV mass contrib-
utes significantly to decreased longitudinal contractile reserve, 
the presence of MS itself was independently associated with 
reduced contractile reserve even when controlled for confound-
ing variables, such as age, LV mass index, and gender. This 
demonstrates that the cluster of cardiovascular risk factors acts 
in concert to adversely affect myocardial function during exer-
cise. Obesity and MS are associated with impaired coronary 
endothelial function and decreased coronary flow reserve that 
may be associated with subendocardial ischemia during exer-
cise.30)31) Increased activation of the renin-angiotensin-aldoste-
rone system in patients with MS may also have a significant 
role in adverse cardiac remodeling and dysfunction.32)
This study was performed in treated hypertensive subjects, 
so the results may be confounded by the influence of BP med-
ications. However, there were no significant differences in the 
proportion of different classes of medications that were admin-
istered (Table 1), and BP medication was assumed to have a 
minimal effect on the results of this study. The lack of an ef-
fect on hemodynamic variables at exercise and exercise dura-
tion also minimizes their influence on the results of this study 
(Table 2). Another limitation of this study is that the presence 
of subclinical atherosclerotic heart disease cannot be complete-
ly ruled out by non-invasive methods. We tried to minimize 
this confounding effect by excluding patients with regional 
wall motion abnormality during exercise echocardiography 
and/or patients with significant ST segment change during 
exercise. 
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